Skip to main content
. 2010 Jun 9;4:53–60. doi: 10.4137/grsb.s4880

Figure 4.

Figure 4.

Predicted effects of administration of the neutralizing antibody specific to FGF23. The administration was given on day 2 (indicated by the arrow), and five different dosages (levels 1 to 5) were employed. A) FGF23 concentration in serum. B) PTH concentration in serum. C) Calcitriol concentration in serum. D) P concentration in serum. E) Urinary output of P expressed as a fraction of the P glomerular load (U_P_R).